Multiple potency of ezetimibe in a patient with macroproteinuric chronic kidney disease and statin-intolerant dyslipidemia
We report that ezetimibe monotherapy for 12months improved lipid profiles in a patient with CKD and statin-intolerant dyslipidemia. Ezetimibe also reduced proteinuria and urinary liver-type fatty acid binding protein levels, improved endothelial function, and decreased carotid atherosclerosis. These findings suggest that ezetimibe monotherapy may have beneficial multipotent effects on renal/vascular function.>
Source: Journal of Cardiology Cases - Category: Cardiology Source Type: research
More News: Antidoxidants | Atorvastatin Calcium | Cardiology | Cardiovascular | Cholesterol | Chronic Kidney Disease | Chronic Pain | Glomeruli | Heart | Learning | Lipitor | Liver | Pain | Proteinuria | Statin Therapy | Universities & Medical Training | Urology & Nephrology | Vytorin | Zetia | Zivast